These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3885761)

  • 1. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
    Mavissakalian M; Michelson L
    J Nerv Ment Dis; 1983 May; 171(5):301-6. PubMed ID: 6343556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB; Steketee G; Kozak MJ; Dugger D
    Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiobsessional effects of clomipramine do not require concomitant affective disorder.
    Katz RJ; DeVeaugh-Geiss J
    Psychiatry Res; 1990 Feb; 31(2):121-9. PubMed ID: 2183254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of antiobsessional and antidepressant effects of tricyclic antidepressants.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Psychopharmacol Bull; 1986; 22(1):161-6. PubMed ID: 3523574
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J; Neziroglu F; Yaryura-Tobias JA
    Psychiatry Res; 1985 Jan; 14(1):85-93. PubMed ID: 3887445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J; Pecknold JC; van den Steen N; Engelsmann F
    Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517
    [No Abstract]   [Full Text] [Related]  

  • 15. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 17. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD; Davis SK; Austin LS
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study.
    Montgomery SA; Montgomery DB; Fineberg N
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):719-27. PubMed ID: 2293252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.